Dongli Holdings Investment Co., Ltd. is a cross-industry technology-intensive specialized company integrating science, industry and agriculture. It is the research center of Zhejiang Provincial Ministerial Company, covering an area of ??100,000 square meters. There are more than 500 employees, involved in the two major industries of medicine and agriculture. Subsidiary intensive companies. As an investment holding company, the company has close subordinate companies including Dongli Tailing Technology Development Co., Ltd., Dongli Tailing Concentrate Feed Co., Ltd., Zhejiang Zhebei Pharmaceutical Co., Ltd., Deqing County Daily Modern Agriculture Development Co., Ltd.
After more than 20 years of hard work, Dongli’s well-known trademarks have achieved fruitful results. The sales volume of Dongli Tailing Enterprise’s Dongli billboard series of compound feed products has ranked among the top 10 in the competition across the country. It has won titles such as one of the top ten famous brands of concentrated feed across the country and a product highly recommended by the Ministry of Finance. Zhebei Medicine has 31 approved drug brands. Key commodities include glucose dipetamethasone injection, tranexamic acid injection, sodium prunellagarate extended-release tablets, Willinin, Vidimin tablets, acyclovir tablets, metformin glibenclamide tablets, inosine oral There are more than 20 kinds of traditional Chinese medicine preparations, raw materials and auxiliary materials, including liquids.
The compound concentrated feed alkalizing agent has become a patented invention product in my country. The company has introduced leading pig raising technology and excellent products into China, and created a live pig experimental industrial base to promote the development of breeding work. Trend, the feed used by Suzhou Taihu No. 3 farm is still majestic and heroic, and it has successively released 2% Donli hurricane series products, compound feed for farms, high-end suckling pig creep feed, Dongli human milk and key concentrated feed, Hypoalbuminemia dietary additives, gold protein, products have steadily occupied the Chinese sales market and are sold to Southeast Asian countries.
The new product Entecavir Sustained Release Tablets developed by the company in collaboration with the General Logistics Department of the People's Liberation Army has been successfully developed and designed, filling the gap in China and taking the company's development to a new height. At the same time, the raw material and excipient axicin Lowe's sales volume ranks first in the country. In addition to meeting the needs of the Chinese pharmaceutical market, some of the raw materials and chemical intermediates are also sold to capitalist countries such as the United Kingdom, the United States, and South Korea. Dongli people are looking further ahead. The company will focus on the theme of condensing development trends, highlighting main business operations, and promoting the improvement of the industrial chain, and will reshape a Dongli development strategy in three years, focusing on medicine and agriculture. Leading the way of attack, giving back to society and serving people with better technology, more exquisite products, and higher quality services.